JPRN-UMIN000013175已完成2 期
Randomized phase II/III study of adjuvant chemotherapy with Adriamycin+Ifosfamide vs Gemcitabine+Docetaxel for high-grade soft tissue sarcoma (JCOG1306, AI vs GD for STS RPII/III) - Randomized phase II/III study of adjuvant chemotherapy with Adriamycin+Ifosfamide vs Gemcitabine+Docetaxel for high-grade soft tissue sarcoma(JCOG1306, AI vs GD for STS RPII/III)
Japan Clinical Oncology Group (JCOG)0 个研究点目标入组 140 人开始时间: 2014年2月17日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Synchronous or metachronous (within 5 years) malignancies except for carcinoma in situ or intramucosal tumors curatively treated with local therapy 2) Active infection requiring systemic therapy 3) Body temperature >= 38 degrees Celsius 4) Women in pregnant, possibly pregnant or breast feeding 5) Psychiatric disease 6) Patients requiring systemic steroid medication 7) Unstable angina within 3 weeks, or with a history of myocardial infarction 8) Poorly controlled hypertension 9) Poorly controlled diabetes mellitus or routine administration of insulin 10) Positive HBs antigen
研究者
相似试验
进行中（未招募）
不适用
A randomized phase III study of adjuvant chemotherapy in patients with completely resected Non-Small-Cell Lung Cancer and low-risk for recurrence: NVALT-8A - NVALT-8AThis is a randomized multicenter phase III study. Patient with a low SUV of the primary tumor prior to surgery will be randomised to four cycles of cisplatin-based chemotherapy or observation in a non-inferiority design.EUCTR2007-002644-21-NLMCG
已完成
3 期
A randomized phase III study of adjuvant chemotherapy with or without low-molecular weight heparin in completely resected non-small-cell lung cancer patients with high-risk for recurrence: NVALT- 8B.10038666lung cancerNon-small cell lung cancerNL-OMON35584niversitair Medisch Centrum Groningen600
尚未招募
3 期
A randomized phase III study of adjuvant chemotherapy in patients with completely resected Non-Small-Cell Lung Cancer and low risk for recurrence: NVALT-8AlungcancerNon-smal cell lung cancer10038666NL-OMON34015niversitair Medisch Centrum Groningen864
进行中（未招募）
不适用
A randomized phase III study of adjuvant chemotherapy with or without low-molecular weight heparin in patients with high risk for recurrence and completely resected non-small-cell lung cancer: NVALT-8B - NVALT-8BThis is a randomized multicenter phase III study. Patient with a high SUVof the primary tumor prior to surgery will be randomised to four cycles of pemetrexed and cisplatin with or without nadroparin for 16 weeks in order to improve the recurrence-free survival rate in these patients.EUCTR2007-002608-16-NLMCG
进行中（未招募）
1 期
Randomized phase III study of neoadjuvant chemotherapy followed by surgery vs. concomitant radiotherapy and chemotherapy in FIGO Ib2, IIa > 4 cm or IIb cervical cancer.Cervical carcinoma (including squamous cell carcinoma, adenosquamous cell or adenocarcinomaMedDRA version: 16.0Level: LLTClassification code 10008242Term: Cervical carcinoma stage IBSystem Organ Class: 100000004864MedDRA version: 16.0Level: LLTClassification code 10008244Term: Cervical carcinoma stage IIASystem Organ Class: 100000004864MedDRA version: 16.0Level: LLTClassification code 10008245Term: Cervical carcinoma stage IIBSystem Organ Class: 100000004864EUCTR2008-003396-52-GBEuropean Organisation for Research and Treatment of Cancer686